Literature DB >> 25972324

Differential diagnostic value of "blue reticulated chondroid-like material" in aneurysmal bone cysts: a classic histopathologic analysis of 215 cases.

Won-Jong Bahk1, Joseph M Mirra2.   

Abstract

OBJECTIVES: Our classic histopathologic study of aneurysmal bone cyst (ABC) revealed that "blue reticulated chondroid-like material" (BRC) is characteristic of ABC.
METHODS: The light microscopic findings were retrospectively analyzed in 215 cases of ABC, including 101 primary and 114 secondary cases. In addition, 22 cases of telangiectatic osteosarcoma (TOS) were drawn from the same source and used as a control.
RESULTS: We found the presence of typical BRC in 24 (23.8%) of 101 cases of primary ABC and in six (5.3%) of 114 cases of secondary ABC, with an overall incidence of 30 (14%). None of the cases of TOS showed BRC. BRC was significantly more common in primary ABC than in secondary ABC (P < .05) and in patients 19 years or younger than in those 20 years or older (P < .05).
CONCLUSIONS: BRC appears to be a unique histopathologic feature of ABC, making it valuable to differentiate benign ABC from TOS. Simple H&E stain can be economically performed anywhere. Copyright© by the American Society for Clinical Pathology.

Entities:  

Keywords:  Aneurysmal bone cyst; Blue reticulated chondroid-like material; Telangiectatic osteosarcoma

Mesh:

Year:  2015        PMID: 25972324     DOI: 10.1309/AJCP33YDDJKFFTSV

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  2 in total

1.  Bizarre parosteal osteochondromatous proliferation: 16 Cases with a focus on histologic variability.

Authors:  Margaret Cocks; Elizabeth Helmke; Carolyn A Meyers; Laura Fayad; Edward McCarthy; Aaron W James
Journal:  J Orthop       Date:  2018-01-31

2.  Diagnosing and discriminating between primary and secondary aneurysmal bone cysts.

Authors:  Hiromi Sasaki; Satoshi Nagano; Hirofumi Shimada; Masahiro Yokouchi; Takao Setoguchi; Yasuhiro Ishidou; Osamu Kunigou; Kosuke Maehara; Setsuro Komiya
Journal:  Oncol Lett       Date:  2017-02-07       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.